• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

你感觉不到的东西可能会伤害你。

What you can't feel can hurt you.

作者信息

Boulton Andrew J M

机构信息

Manchester Diabetes Centre, 193 Hathersage Rd, Manchester M13 0JE, England.

出版信息

J Am Podiatr Med Assoc. 2010 Sep-Oct;100(5):349-52. doi: 10.7547/1000349.

DOI:10.7547/1000349
PMID:20847348
Abstract

Throughout our medical training, we are taught how to manage patients who present with symptoms: perform a clinical examination, make a diagnosis, and develop a management plan. However, virtually no time is spent on teaching us how to manage patients who have no symptoms because they have lost the ability to feel pain, that is, patients with peripheral neuropathy. The lifetime incidence of foot ulceration in people with diabetes has been estimated to be as high as 25%, and a variety of contributory factors result in a foot being at risk for ulceration. Most important among these factors is peripheral neuropathy, or the loss of the ability to feel pain, temperature, or pressure sensation in the feet and lower legs. Up to 50% of older type 2 diabetic patients have evidence of sensory loss, putting them at risk for foot ulceration. If we are to succeed in reducing the high incidence of foot ulcers, regular screening for peripheral neuropathy is vital in all patients with diabetes. Those found to have any risk factors for foot ulceration require special education and more frequent review, particularly by podiatric physicians. The key message is, therefore, that neuropathic symptoms correlate poorly with sensory loss and that their absence must never be equated with lack of risk of foot ulceration. If we are to succeed in reducing the high incidence of foot ulceration and particularly recurrent ulceration, we must realize that with loss of pain there is also diminished motivation in the healing and prevention of injury.

摘要

在整个医学培训过程中,我们学习了如何治疗有症状的患者:进行临床检查、做出诊断并制定治疗方案。然而,几乎没有时间教我们如何治疗没有症状的患者,这些患者因为失去了疼痛感知能力,也就是患有周围神经病变。据估计,糖尿病患者足部溃疡的终生发病率高达25%,多种促成因素导致足部有溃疡风险。其中最重要的因素是周围神经病变,即足部和小腿失去疼痛、温度或压力感觉的能力。高达50%的老年2型糖尿病患者有感觉丧失的迹象,这使他们面临足部溃疡的风险。如果我们要成功降低足部溃疡的高发病率,对所有糖尿病患者定期筛查周围神经病变至关重要。那些被发现有任何足部溃疡风险因素的患者需要接受特殊教育并更频繁地复诊,尤其是由足病医生进行检查。因此,关键信息是,神经病变症状与感觉丧失的相关性很差,绝不能将无症状等同于没有足部溃疡风险。如果我们要成功降低足部溃疡尤其是复发性溃疡的高发病率,我们必须认识到,随着疼痛的丧失,愈合和预防损伤的动力也会减弱。

相似文献

1
What you can't feel can hurt you.你感觉不到的东西可能会伤害你。
J Am Podiatr Med Assoc. 2010 Sep-Oct;100(5):349-52. doi: 10.7547/1000349.
2
What you can't feel can hurt you.你无法感受到的东西也可能伤害你。
J Vasc Surg. 2010 Sep;52(3 Suppl):28S-30S. doi: 10.1016/j.jvs.2010.06.005.
3
The diabetic foot: perspectives from Chennai, South India.糖尿病足:来自印度南部金奈的观点
Int J Low Extrem Wounds. 2007 Mar;6(1):34-6. doi: 10.1177/1534734606297987.
4
The pathway to foot ulceration in diabetes.糖尿病患者足部溃疡的发病途径。
Med Clin North Am. 2013 Sep;97(5):775-90. doi: 10.1016/j.mcna.2013.03.007. Epub 2013 Apr 29.
5
Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial.识别糖尿病足溃疡高危人群的筛查技术:一项前瞻性多中心试验。
Diabetes Care. 2000 May;23(5):606-11. doi: 10.2337/diacare.23.5.606.
6
Evaluation of "care of the foot" as a risk factor for diabetic foot ulceration: the role of internal physicians.评估“足部护理”作为糖尿病足溃疡危险因素的作用:内科医生的角色。
Niger J Clin Pract. 2009 Mar;12(1):42-6.
7
Preventing foot ulcers in patients with diabetes.预防糖尿病患者足部溃疡
JAMA. 2005 Jan 12;293(2):217-28. doi: 10.1001/jama.293.2.217.
8
The association between callus formation, high pressures and neuropathy in diabetic foot ulceration.糖尿病足溃疡中骨痂形成、高压与神经病变之间的关联。
Diabet Med. 1996 Nov;13(11):979-82. doi: 10.1002/(SICI)1096-9136(199611)13:11<979::AID-DIA267>3.0.CO;2-A.
9
Diabetic neuropathy and foot complications.糖尿病神经病变与足部并发症。
Handb Clin Neurol. 2014;126:97-107. doi: 10.1016/B978-0-444-53480-4.00008-4.
10
Shear-reducing insoles to prevent foot ulceration in high-risk diabetic patients.抗剪切鞋垫预防高危糖尿病患者足部溃疡。
Adv Skin Wound Care. 2012 Nov;25(11):519-24; quiz 525-6. doi: 10.1097/01.ASW.0000422625.17407.93.

引用本文的文献

1
Evaluation of orthotic insoles for people with diabetes who are at-risk of first ulceration.糖尿病高危足溃疡人群矫形鞋垫的评价。
J Foot Ankle Res. 2019 Jun 18;12:35. doi: 10.1186/s13047-019-0344-z. eCollection 2019.
2
Current concepts for the evaluation and management of diabetic foot ulcers.糖尿病足溃疡评估与管理的当前概念
EFORT Open Rev. 2018 Sep 27;3(9):513-525. doi: 10.1302/2058-5241.3.180010. eCollection 2018 Sep.
3
Physiological and psychological challenges of increasing physical activity and exercise in patients at risk of diabetic foot ulcers: a critical review.
增加身体活动和锻炼对糖尿病足溃疡高危患者的生理和心理挑战:一项批判性综述
Diabetes Metab Res Rev. 2016 Nov;32(8):791-804. doi: 10.1002/dmrr.2817. Epub 2016 Jun 10.
4
Unlocking the biology of RAGE in diabetic microvascular complications.揭示糖尿病微血管并发症中晚期糖基化终末产物受体的生物学机制
Trends Endocrinol Metab. 2014 Jan;25(1):15-22. doi: 10.1016/j.tem.2013.08.002. Epub 2013 Sep 3.
5
RNAi-based therapeutic strategies for metabolic disease.基于 RNAi 的代谢疾病治疗策略。
Nat Rev Endocrinol. 2011 Apr 19;7(8):473-84. doi: 10.1038/nrendo.2011.57.